期刊文献+

荧光原位杂交检测宫颈细胞hTERC基因扩增及其临床意义

Clinical significance of hTERC gene amplification in cervical squamous epithelial cells detected by fluorescence in situ hybridization
暂未订购
导出
摘要 目的探讨端粒酶基因(hTERC)扩增与宫颈上皮内肿瘤(CIN)和宫颈癌发生发展的关系及临床意义。方法应用荧光原位杂交技术检测100例存在宫颈病变患者的宫颈脱落细胞中hTERC基因的扩增情况。结果 100例各类宫颈细胞病变中,hTERC基因扩增比例分别为:CIN1组13.3%(4/30),CIN2组71.0%(22/31),CIN3组和宫颈癌组均为100%(19/19,20/20),各组比较差异均有统计学意义(P<0.01)。结论宫颈CIN和宫颈癌细胞hTERC基因均有扩增,且扩增率随病变的进展而增加;高级别CIN和癌的扩增率明显高于低级别CIN;检测hTERC基因扩增可以作为宫颈CIN和宫颈癌筛查及预后评估的重要指标。 Objective To study the relationship and clinical significance between human telomerase gene amplification and development of cervical intraepithelial neoplasm and cervical squamous cancer.Methods hTERC gene amplification were detected by FISH in cytological samples from 100 cases of CIN /cervical squamous cancer and 20 cases of normal cervix.Results In 100 cases of various types of cervical cell lesions,the abnormal amplification ratio of hTERC gene was:13.3%(4/30) in CIN1 group,71.0%(22/31) in CIN2 group,CIN 3 group and cervical cancer squamous group were 100%(19/19,20/20),each group compare difference to all have statistical significance(P 0.01).Conclusion hTERC gene was amplified both in CIN and cervical squamous cancer cells,and the amplification rate increases with lesion progression.The amplification rate of high grade CIN and squamous cancer was significantly higher than that of low grade CIN.Detection of hTERC gene amplification can be used as an important indicator in cervical CIN and cervical cancer screening and prognostic evaluation.
出处 《中国医药科学》 2012年第16期103-104,110,共3页 China Medicine And Pharmacy
关键词 宫颈上皮内肿瘤 宫颈癌 HTERC基因 荧光原位杂交技术 Cervical intraepithelial neoplasm Cervical cancer hTERC gene Fluorescence in situ hybridization
  • 相关文献

参考文献1

二级参考文献10

  • 1Stoltzfus P,Heselmeyer-Haddad K,Castro J, et al.Gain of chromosome 3q is an early and consistent genetic aberration in carcinomas of the vulva[].International Journal of Gynecological Cancer.2005
  • 2Volpi EV,Bridger JM.FISH glossary: an overview of the fluorescence in situ hybridization technique[].Biotech- niques.2008
  • 3Matthew Meyerson.Role of telomerase in normal and cancer cells[].Journal of Clinical Oncology.2000
  • 4Zur Hausen H.Papillomaviruses and cancer: from basic studies to clinical application[].Nature Reviews Cancer.2002
  • 5Baldwin P,Laskey R,Coleman N.Translational approaches to improving cervical screening[].Nature Reviews Cancer.2003
  • 6Reesink-Peters N,Helder MN,Wisman GB,et al.Detection of telomerase, its components, and human papiEomavirus in cervical scrapings as a tool for triage in women with cervical dysplasia[].Journal of Clinical Pathology.2003
  • 7von,Knebel Doeberitz,M.New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections[].European Journal of Cancer.2002
  • 8Melshei mer P,Vinokurova S,Wentzensen N,et al.DNAaneu-ploidy andintegration of human papillomavirus type16e6/e7on-cogenes in intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri[].Clinical Cancer Research.2004
  • 9Maria Kirchhoff Hanne Rose Bodil Laub Petersen Jan Maahr Tommy Gerdes John Philip and Claes Lundsteen.Comparative genomic hybridization reveals non-random chromosomal aberrations in early preinvasive cervical lesions[].Cancer Genetics and Cytogenetics.2001
  • 10.The 1991 Bethesda System for reporting cervical/vaginal cytologic d iag-noses:report of the 1991 Bethesda W orkshop[].The Journal of The American Medical Association.1991

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部